Skip to main content

Table 2 Outcomes in different types ARDS patients

From: Comparison of community-acquired, hospital-acquired, and intensive care unit-acquired acute respiratory distress syndrome: a prospective observational cohort study

Outcomes Community-acquired ARDS Hospital-acquired ARDS ICU-acquired ARDS p
  (n = 70) (n = 83) (n = 143)  
Mortality –no.(% [95 % CI])
 In ICU 26 (37*[26–49]) 51 (61[51–72]) 75 (52[44–61]) 0.001
 At 28-day 31 (44*[33–56]) 56 (68[57–78]) 89 (62[54–70]) 0.012
 At 60-day 33 (47*[35–59]) 58 (70[60–80]) 92 (64[56–72]) 0.001
 At 90-day 33 (47*[35–59]) 59 (71[61–81]) 97 (68[60–76]) 0.001
 In hospital 34 (49*[37–60]) 61 (74[64–83]) 97 (68[60–76]) 0.001
No. of ventilator-free days, days 1 to 28 16 ± 9 14 ± 10 11 ± 9 0.001
No. of ICU-free days, Days 1 to 28 8 ± 10* 4 ± 8 3 ± 6 0.001
  1. Abbreviations: ARDS acute respiratory distress syndrome, MV mechanical ventilation, LOS length of stay, ICU intensive care unit
  2. All values are expressed as No of patients (% [95 % CI]) or mean ± SD
  3. * p < 0.05: Community-acquired ARDS vs. hospital-acquired ARDS and vs ICU-acquired ARDS
  4. p < 0.05: ICU-acquired ARDS vs. Community-acquired ARDS and vs Hospital-acquired ARDS